Related Experiment Video

Updated: Jun 5, 2026

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy

Erlong Zhang1, Chao Zhang, Yongping Su

  • 1Institute of Combined Injury, State Key Laboratory of Trauma, Burns and Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, and Department of Orthopedics, Xinqiao Hospital, Chongqing 400038, China.

Drug Discovery Today
|December 25, 2010
PubMed

Insights

Developing multifunctional agents for simultaneous tumor targeting, imaging, and treatment is key for personalized oncology. Targeting mitochondria offers novel strategies for cancer therapy using advanced drug delivery systems.

Area of Science:

  • Oncology
  • Nanotechnology
  • Mitochondrial Biology

Background:

  • Multifunctional agents are crucial for personalized oncology, enabling simultaneous tumor targeting, imaging, and treatment.
  • Mitochondria play vital roles in cancer development and progression, making them attractive therapeutic targets.

Purpose of the Study:

  • To explore the development of multifunctional agents for cancer research.
  • To investigate novel mitochondrial targets and drug delivery systems for cancer therapy.
  • To broaden tumor targeting concepts using multifunctional nanostructures and chemical compounds.

Main Methods:

  • Review of current research on multifunctional agents in cancer therapy.
  • Analysis of mitochondrial roles in cancer progression.
  • Exploration of nanostructures and chemical compounds for targeted delivery.

Main Results:

  • Multifunctional agents offer simultaneous tumor targeting, imaging, and treatment capabilities.
  • Mitochondrial targeting presents a promising avenue for novel cancer treatment strategies.
  • Nanostructures and chemical compounds enhance tumor targeting and enable mitochondrially targeted therapy.

Conclusions:

  • Multifunctional agents are essential for advancing personalized oncology.
  • Targeting mitochondria provides innovative solutions for cancer treatment.
  • Nanotechnology and advanced chemical compounds are key to developing effective mitochondrially targeted cancer therapies.

More Related Videos

Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...